A detailed history of Envestnet Asset Management Inc transactions in Argenx Se stock. As of the latest transaction made, Envestnet Asset Management Inc holds 67,891 shares of ARGX stock, worth $38.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,891
Previous 62,999 7.77%
Holding current value
$38.3 Million
Previous $27.1 Million 35.91%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$434.22 - $551.9 $2.12 Million - $2.7 Million
4,892 Added 7.77%
67,891 $36.8 Million
Q2 2024

Aug 08, 2024

BUY
$356.01 - $451.55 $2.72 Million - $3.45 Million
7,645 Added 13.81%
62,999 $27.1 Million
Q1 2024

May 13, 2024

BUY
$356.95 - $413.29 $2.66 Million - $3.08 Million
7,454 Added 15.56%
55,354 $21.8 Million
Q4 2023

Feb 13, 2024

BUY
$338.91 - $506.01 $1.36 Million - $2.03 Million
4,013 Added 9.14%
47,900 $18.2 Million
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $9.58 Million - $14.2 Million
25,940 Added 144.54%
43,887 $21.6 Million
Q2 2023

Aug 04, 2023

BUY
$360.14 - $422.58 $887,745 - $1.04 Million
2,465 Added 15.92%
17,947 $6.99 Million
Q1 2023

May 11, 2023

BUY
$334.23 - $403.65 $98,263 - $118,673
294 Added 1.94%
15,482 $5.77 Million
Q4 2022

Feb 07, 2023

SELL
$342.17 - $402.31 $5,132 - $6,034
-15 Reduced 0.1%
15,188 $5.75 Million
Q3 2022

Nov 10, 2022

BUY
$343.2 - $395.75 $580,694 - $669,609
1,692 Added 12.52%
15,203 $5.37 Million
Q2 2022

Aug 03, 2022

BUY
$269.58 - $378.88 $134,520 - $189,061
499 Added 3.83%
13,511 $5.12 Million
Q1 2022

May 04, 2022

BUY
$254.45 - $351.06 $1.35 Million - $1.86 Million
5,294 Added 68.59%
13,012 $4.1 Million
Q4 2021

Feb 04, 2022

BUY
$272.01 - $353.03 $347,900 - $451,525
1,279 Added 19.86%
7,718 $2.7 Million
Q3 2021

Oct 07, 2021

BUY
$295.0 - $350.58 $71,390 - $84,840
242 Added 3.91%
6,439 $1.94 Million
Q2 2021

Aug 04, 2021

SELL
$257.11 - $319.92 $1.35 Million - $1.68 Million
-5,255 Reduced 45.89%
6,197 $1.87 Million
Q1 2021

May 04, 2021

BUY
$268.3 - $380.31 $834,413 - $1.18 Million
3,110 Added 37.28%
11,452 $3.15 Million
Q4 2020

Feb 02, 2021

BUY
$248.13 - $308.36 $186,841 - $232,195
753 Added 9.92%
8,342 $2.45 Million
Q3 2020

Oct 09, 2020

SELL
$215.51 - $272.51 $75,428 - $95,378
-350 Reduced 4.41%
7,589 $1.99 Million
Q2 2020

Jul 08, 2020

SELL
$127.44 - $232.72 $382 - $698
-3 Reduced 0.04%
7,939 $1.79 Million
Q1 2020

Apr 23, 2020

BUY
$108.83 - $165.23 $80,751 - $122,600
742 Added 10.31%
7,942 $1.05 Million
Q4 2019

Feb 11, 2020

BUY
$106.59 - $164.21 $299,091 - $460,773
2,806 Added 63.86%
7,200 $1.16 Million
Q3 2019

Oct 17, 2019

SELL
$113.31 - $150.51 $29,233 - $38,831
-258 Reduced 5.55%
4,394 $501,000
Q2 2019

Aug 02, 2019

SELL
$115.0 - $141.58 $18,515 - $22,794
-161 Reduced 3.35%
4,652 $659,000
Q1 2019

May 10, 2019

SELL
$98.85 - $134.59 $21,549 - $29,340
-218 Reduced 4.33%
4,813 $601,000
Q4 2018

Feb 13, 2019

BUY
$63.81 - $109.82 $321,028 - $552,504
5,031 New
5,031 $483,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.